Oral and Maxillofacial Pathology| Volume 93, ISSUE 4, P440-445, April 2002

Polymorphisms of xenobiotic metabolizing genes in oropharyngeal carcinoma


      Objective. The objective was to determine the prevalence of the polymorphisms of the microsomal epoxide hydrolase (Ephx1 ), glutathione S-transferase μ1 (GSTM1 ), θ1 (GSTT1 ), and π1 (GSTP1 ) genes in patients with oropharyngeal carcinoma. Study Design. Gene polymorphisms in 137 patients with oropharyngeal carcinoma were determined by polymerase chain reaction and restriction enzyme digestion for xenobiotic metabolizing enzymes that have been implicated in the carcinogenesis of tobacco-related neoplasias and compared with a population sample of 99 persons. Results. At Ephx1 (microsomal epoxide hydrolase) codon 113, an overrepresentation of the greater activity genotype (Tyr/Tyr ) was observed for male ever-smokers alone, both male and female ever-smokers, female never-smokers alone, and in both male and female never-smokers, compared with a control population sample. At codon 139, Ephx1 showed no differences. There was an overrepresentation of homozygosity for the GSTT1 (glutathione S-transferase θ1) null allele [but not for the GSTM1 (glutathione S-transferase μ1) null allele] in ever-smokers, when compared with controls. Polymorphisms at the GSTP1 (glutathione S-transferase π1) locus did not show differences versus controls, although in the never-smoker cancer sample there was a higher prevalence of the B/B genotype compared with ever-smokers. Conclusion. The Ephx1 codon 113 Tyr/Tyr variant, as well as homozygosity for the GSTT1 null allele, is associated with oropharyngeal carcinogenesis. (Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;93:440-5)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


        • Rojas M
        • Cascorbi I
        • Alexandrov K
        • Kriek E
        • Auburtin G
        • Mayer L
        • et al.
        Modulation of benzo[a ]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism.
        Carcinogenesis. 2000; 21: 35-41
        • Sato M
        • Sato T
        • Izumo T
        • Amagasa T
        Genetic polymorphism of drug-metabolizing enzymes and susceptibility to oral cancer.
        Carcinogenesis. 1999; 20: 1927-1931
        • Trizna Z
        • Clayman GL
        • Spitz MR
        • Briggs KL
        • Goepfert H
        Glutathione s-transferase genotypes as risk factors for head and neck cancer.
        Am J Surg. 1995; 170: 499-501
        • Nair UJ
        • Nair J
        • Mathew B
        • Bartsch H
        Glutathione S-transferase M1 and T1 null genotypes as risk factors for oral leukoplakia in ethnic Indian betel quid/tobacco chewers.
        Carcinogenesis. 1999; 20: 743-748
        • Park JY
        • Muscat JE
        • Ren Q
        • Schantz SP
        • Harwick RD
        • Stern JC
        • et al.
        CYP1A1 and GSTM1 polymorphisms and oral cancer risk.
        Cancer Epidemiol Biomarkers Prev. 1997; 6: 791-797
        • Hassett C
        • Aicher L
        • Sidhu JS
        • Omiecinski CJ
        Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants.
        Hum Mol Genet. 1994; 3: 421-428
        • Chen CL
        • Liu Q
        • Relling MV
        Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks.
        Pharmacogenetics. 1996; 6: 187-191
        • Nedelcheva Kristensen V
        • Andersen TI
        • Erikstein B
        • Geitvik G
        • Skovlund E
        • Nesland JM
        • et al.
        Single tube multiplex polymerase chain reaction genotype analysis of GSTM1, GSTT1 and GSTP1 : relation of genotypes to TP53 tumor status and clinicopathological variables in breast cancer patients.
        Pharmacogenetics. 1998; 8: 441-447
        • Agresti A
        Categorical data analysis.
        John Wiley & Sons, New York1990
      1. Fourth Edition. SAS/STAT® User's Guide, Version 6. Volume 2. SAS Institute Inc, Cary (NC)1998
        • Jourenkova-Mironova N
        • Mitrunen K
        • Bouchardy C
        • Dayer P
        • Benhamou S
        • Hirvonen A
        High-activity microsomal epoxide hydrolase genotypes and the risk of oral, pharynx, and larynx cancers.
        Cancer Res. 2000; 60: 534-536
        • Kessler R
        • Hamou MF
        • Albertoni M
        • de Tribolet N
        • Arand M
        • Van Meir EG
        Identification of the putative brain tumor antigen BF7/GE2 as the (de)toxifying enzyme microsomal epoxide hydrolase.
        Cancer Res. 2000; 60: 1403-1409
        • McNees AG
        • O'Donnell M
        • Horton PH
        • Kim HY
        • Kim SJ
        • Harris CM
        • et al.
        Lack of correlation between in vitro and in vivo replication of precisely defined benz-a-anthracene adducted DNAs.
        J Biol Chem. 1997; 272: 33211-33219
        • Yuen J
        • Ekbom A
        • Trichopoulos D
        • Hsieh CC
        • Adami HO
        Season of birth and breast cancer risk in Sweden.
        Br J Cancer. 1994; 70: 564-568
        • Amador AG
        • Eckert G
        • Larby K
        • Hartsfield Jr, JK
        Seasonality of birth in patients with various types of reproductive tract or head and neck neoplasias.
        Transac Ill St Acad Sci. 2000; 93: 74
        • Kristoffersen S
        • Harveit F
        Is a woman's date of birth related to her risk of developing breast cancer?.
        Oncol Rep. 2000; 7: 245-247